NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Equivalent to Atorvastatin 40 mg (As pellets) +Clopidogrel Bisulphate IP Equivalent to Clopidogrel 75 mg (As pellets) for Macleods Pharmaceuticals Limited (Manufacturer) & (Marketer)

Jan 24, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on January 23, 2026, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Equivalent to Atorvastatin 40 mg (As pellets) +Clopidogrel Bisulphate IP Equivalent to Clopidogrel 75 mg (As pellets) for Macleods Pharmaceuticals Limited (Manufacturer) & (Marketer).

The following has been stated: -

•Each hard gelatin capsule contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 40 mg (As pellets) +Clopidogrel Bisulphate IP Equivalent to Clopidogrel 75 mg(As pellets) for Macleods Pharmaceuticals Limited (Manufacturer) &(Marketer), and the retail price is 30.09 Rs.

 [Notification No.: 19(4992)/2026/NPPA/Div.III/12971/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT